DexCom, Inc. (DXCM)
Health Care – SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Headquarters
- United States
- Employees
- 11,100
- Market Cap
- $28.9B
About DexCom, Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
SentiSense also tracks daily options readings for DexCom, Inc.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
DexCom, Inc. stock analysis, sentiment tracking, and market intelligence on SentiSense.